Quanterix (QTRX) Amortization of Deferred Charges (2022 - 2026)
Quanterix (QTRX) posted Amortization of Deferred Charges of $797000.0 for Q1 2026, down 22.09% on a QoQ basis from $1.0 million in Q4 2025, and up 42.07% year-over-year from $561000.0 in Q1 2025.
Quanterix (QTRX) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Quanterix's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $797000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges rose 42.07% year-over-year to $797000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 67.86% YoY) and the FY2025 annual result came in at $3.1 million, up 62.76% from the prior year.
- Amortization of Deferred Charges was $797000.0 for Q1 2026 at Quanterix, down from $1.0 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $1.2 million in Q3 2025 and bottomed at -$384000.0 in Q4 2022.
- A 5-year average of $505066.7 and a median of $516000.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges soared 229.43% — and 2024, when it tumbled 45.81%.
- Quanterix's Amortization of Deferred Charges stood at -$384000.0 in 2022, then surged by 229.43% to $497000.0 in 2023, then climbed by 5.03% to $522000.0 in 2024, then surged by 95.98% to $1.0 million in 2025, then fell by 22.09% to $797000.0 in 2026.
- Business Quant data shows QTRX's Amortization of Deferred Charges at $797000.0 in Q1 2026, $1.0 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Quanterix | 171.71 Mn | 72.44 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 797,000.00 |
| Mar 31, 2026 | 797,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 289,000.00 |
| Jun 30, 2025 | 289,000.00 |
| Mar 31, 2025 | 561,000.00 |
| Mar 31, 2025 | 561,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 531,000.00 |
| Sep 30, 2024 | 531,000.00 |
| Jun 30, 2024 | 362,000.00 |
| Jun 30, 2024 | 362,000.00 |
| Mar 31, 2024 | 478,000.00 |
| Mar 31, 2024 | 478,000.00 |
| Dec 31, 2023 | 497,000.00 |
| Dec 31, 2023 | 497,000.00 |